The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Mini arthrotomy or arthroscopic surgical implantation of the Nanochon Chondrograft
Fraser Orthopaedic Institute
New Westminster, British Columbia, Canada
RECRUITINGUniversity of British Columbia
Vancouver, British Columbia, Canada
NOT_YET_RECRUITINGSerious Adverse Device Event Effects
Absence of Serious Adverse Device Event Effects (SADEs) through Month 12
Time frame: Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.